Improving symptoms by removing the Essure contraceptive implant
Official title: Prospective Multicenter Study of the Improvement of Symptoms After Removal of the Essure® Contraceptive Implant
Run by Hospices Civils de Lyon · NCT06355713 · Data updated 2026-11-12
This study is testing if removing the Essure contraceptive implant can help women aged 35 to 75 who are having problems with the device feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 75 Years |
| Sex | Women only |
| Enrollment | 444 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 10 sites (Angers and 9 other locations) |
| Status | Recruiting |
| Started | February 17, 2025 |
| Main results expected | April 17, 2032 |
| Study ends | February 17, 2037 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06355713 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 35 to 75 with at least one Essure® implant who are symptomatic and scheduled for explantation.
✕Probably not a fit
Patients who do not have an Essure® implant or are asymptomatic may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of removing the Essure® contraceptive implant in women aged 35 to 75 who are experiencing symptoms related to the device. The study aims to assess symptom improvement following explantation through various surgical methods, including laparoscopy and robotic surgery. Participants will undergo MRI-PET examinations, blood and urine tests, and complete questionnaires to evaluate their health status pre- and post-surgery. The trial addresses a significant public health issue, as many women with these implants have not received the necessary treatment for their symptoms.
Why it matters
Potential benefit: If successful, this study could provide significant relief for women suffering from complications related to the Essure® implant.
How similar studies have gone: Previous studies have shown significant symptom improvement after explantation of the Essure® implant, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Inclusion Criteria \* : ESSURE Group: * woman aged 35 to 75 * patient with at least one Essure® implant * surgical intervention planned because the patient is symptomatic: removal of the Essure® implant(s) * planned intervention via vaginal route, laparoscopy, robotic surgery, or Transvaginal natural orifice transluminal endoscopic surgery (VNotes) * patient having given free, informed and signed consent Selection for MRI-PET examination: * if the answer is "poor" or "bad" to the first question of the SF-12 pre-operatively * no hysterectomy * no analgesic treatment, or treatment stopped 48 hours before the examination * no psychotropic treatment (anxiolytics, hypnotics (sleeping pills), antidepressants, mood stabilizers, neuroleptics) * patient having given free, informed and signed consent Control group: * woman aged 35 to 75 * planned surgical intervention: salpingectomy with or without hysterectomy for benign indication * planned intervention via vaginal route, laparoscopy, robotic surgery, or VNotes * patient having given free, informed and signed consent Selection for MRI-PET examination: * age matching (+/- 5 years) with Essure® patients who have had an MRI-PET * matching on surgical technique with Essure® patients who have had an MRI-PET: salpingectomy with or without hysterectomy * no analgesic treatment, or treatment stopped 48 hours before the examination * no psychotropic treatment (anxiolytics, hypnotics (sleeping pills), antidepressants, mood stabilizers, neuroleptics) * patient having given free, informed and signed consent * Exclusion Criteria \* : ESSURE Group: * asymptomatic patient * planned intervention by laparotomy * patient potentially exposed to other heavy metals: wearer of metallic orthopedic equipment (hip or knee prosthesis, etc.), wearer of coronary stent, or tubal ligation clip * inability to understand the information given * persons deprived of liberty by a judicial or administrative decision * people undergoing psychiatric care * people admitted to a health or social establishment for purposes other than research * adults subject to a legal protection measure (guardianship, curatorship) * people not affiliated to a social security scheme or beneficiaries of a similar scheme * person participating in another interventional research that may interfere with the research Selection for MRI-PET examination: * claustrophobia * dosimetry of all radiological examinations over the past year not acceptable Control Group : * current pregnancy * patient with cancer * patient who has already had an Essure® implant removed * patient potentially exposed to heavy metals: wearer of metallic orthopedic equipment (hip or knee prosthesis, etc.), wearer of coronary stent, or tubal ligation clip * planned intervention by laparotomy * inability to understand the information given * persons deprived of liberty by a judicial or administrative decision * people undergoing psychiatric care * people admitted to a health or social establishment for purposes other than research * adults subject to a legal protection measure (guardianship, curatorship) * people not affiliated to a social security scheme or beneficiaries of a similar scheme * person participating in another interventional research that may interfere with the research Selection for MRI-PET examination: * claustrophobia * dosimetry of all radiological examinations over the past year not acceptable
Where it's running
-
Hôpital Femme Mère Enfant (Hospices Civils de Lyon)
Bron, France Recruiting -
CHU de Angers
Angers, France Not yet recruiting -
Hôpital Bicêtre
Le Kremlin-Bicêtre, France Not yet recruiting -
Hôpital Jeanne de Flandres
Lille, France Not yet recruiting -
Hôpital de La Conception
Marseille, France Not yet recruiting -
Institut Mère Enfant Alix de Champagne, CHU Reims
Reims, France Not yet recruiting
Show 4 more locations
-
CHU de Rouen
Rouen, France Not yet recruiting -
Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, France Not yet recruiting -
Hôpital Paule de Viguier, CHU de Toulouse
Toulouse, France Not yet recruiting -
Hôpital André Mignot, Centre Hospitalier de Versailles
Versailles, France Not yet recruiting
Study contacts
- Study coordinator: Gautier Chene, PU,PH
- Email: gautier.chene@chu-lyon.fr
- Phone: 0472355870
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Zirconia versus titanium abutments for single posterior implant restorations
This study will test whether customized zirconia abutments or standard titanium abutments better protect the tissues, limit bone loss, and improve oral quality of life for adults receiving a single posterior implant crown.
-
Xperience™ versus dilute povidone-iodine to prevent infections after implant-based breast reconstruction
This trial will test whether Xperience™ surgical irrigation reduces infection and complication rates compared with dilute povidone-iodine in women 18 and older having implant-based breast reconstruction after mastectomy.
-
Comparing immediate implant placement techniques for dental implants
This study is testing two different ways to place dental implants right away to see which method helps them stay stable and have fewer problems.
-
Comparing immediate and delayed loading of maxillary overdenture implants
This study is testing whether putting in maxillary overdenture implants right away or waiting three months affects bone loss and other outcomes for patients over three years.
-
Comparing two methods for soft tissue augmentation at dental implant sites
This study is testing which method works better for improving soft tissue around dental implants by comparing a tissue graft from the patient to a special skin substitute.
-
Evaluating the safety and effectiveness of pediatric orthopedic implants
This study is testing how safe and effective orthopedic implants are for kids with fractures and limb deformities to see how they perform over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.